Repatha (evolocumab) - Amgen, Astellas
First histologically confirmed case of evolocumab-induced urticarial vasculitis with rechallenge. (PubMed, Eur J Dermatol) - Aug 30, 2026 - No abstract available 
Journal • Dermatology • Immunology • Urticaria • Vasculitis
http://www.ncbi.nlm.nih.gov/pubmed/42665972
 
Alberto Mota; Carolina Leal; Gilberto Pïres Rosa; Manuel Bernardo Costa; Rafael Baptista Santos
 
Aug 30, 2026
 
Prev Next